Last reviewed · How we verify
FBL-MTX
At a glance
| Generic name | FBL-MTX |
|---|---|
| Sponsor | SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis (PHASE2)
- Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTX (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FBL-MTX CI brief — competitive landscape report
- FBL-MTX updates RSS · CI watch RSS
- SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd portfolio CI